Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
4
×
deals
fda
4
×
life sciences
national blog main
national top stories
4
×
boston blog main
new york blog main
new york top stories
alnylam pharmaceuticals
boston top stories
clinical trials
medical devices
new york
novartis
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
startups
abbvie
akouos
alex gorsky
alirocumab
allergan
amag pharmaceuticals
amgen
amunix
anirvan ghosh
ashley mcevoy
astrazeneca
atrial fibrillation
auris health
biogen
bluerock therapeutics
boston
boston scientific
boulder/denver blog main
boulder/denver top stories
What
deal
4
×
acquire
billion
cash
medicines
plans
startup
acquiring
acquisitions
adding
agreed
announced
atrial
auris
bio
boston
brings
builds
business
buy
ceo
cholesterol
collabs
company
company’s
compound
continues
covid
cryterion
daniel
developer
device
drug
fda
fibrillation
gilead
gilead’s
health
heart
help
Language
unset
Current search:
biotech
×
fda
×
" national top stories "
×
photo
×
deal
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion